Search Results

Baxter Increases Dividend and Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced an increase in the company's quarterly cash dividend to a rate of $0.29 per share of common stock. This represents an approximately 3.5% increase over the previous quarterly dividend rate of $0.28 per share. Baxter's Board of Directors declared the dividend payable on July 1, 2022, to stockholders of record as of June 3, 2022. The indicated annual dividend rate is now $1.16 per share of common stock.

Baxter Reports First-Quarter 2022 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2022.

Baxter Highlights New Data at SCCM Critical Care Congress Showing Hemodynamic Monitoring May Help Predict Patient Outcomes

Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the findings of an observational study on data from the Starling Registry. The Baxter-sponsored study found that monitoring stroke volume and cardiac output trends for patients with critical conditions may provide insight into cardiac function and help predict patient outcomes, including mortality.

Partnering to Empower Health

How Americares partner clinics in the United States are helping low-income, uninsured and underinsured patients address food insecurity and manage their health through technology  

Baxter Announces U.S. FDA Clearance of ST Set Used to Help Treat Acute Kidney Injury Patients in the Hospital

Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ST Set used in continuous renal replacement therapy (CRRT). The ST Set is a pre-connected, disposable, extracorporeal (outside the body) circuit that provides blood purification through a semipermeable membrane to be used with the PrisMax or Prismaflex control units (monitors).

Baxter to Host First-Quarter 2022 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2022 financial results on Thursday, April 28, 2022 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/EmxweYhQ to pre-register for the call and receive the call information.

Responding to Global Water Challenges

How several of our efforts are making an impact around the world  

Lessons from the Connectivity Frontlines

When connecting medical devices to the hospital electronic medical record (EMR), it takes a few key ingredients to move from planning to a successful 'go live.'

For the Health of the Community

Employees Justin and Ken discuss healthcare disparities for Black Americans, wellness, and Baxter's commitment to racial justice.

Leading Baxter's Longest-Operating Plant

Betsy, Site Director at Baxter's Cleveland, Mississippi (U.S.) manufacturing plant, shares her perspective on how connecting with employees and encouraging diversity of thought leads to better planning and process improvements.